Sancilio & Company, Inc. develops, manufactures, and distributes biopharmaceutical products in the United States and internationally. Its cardiovascular health products include OCEAN BLUE PROFESSIONAL OMEGA-3 2100, which is made from fish oils to decrease the risk of arrhythmias. The company also provides dental health products, including LUDENT SODIUM FLUORIDE CHEWABLE TABLETS that provide fluoride to the children; MVC MULTIVITAMIN WITH FLUORIDE CHEWABLE TABLETS, which contain vitamins and minerals; and sodium fluoride drops. In addition, it offers women’s health products, which include Mylk, a multivitamin/mineral/essential fatty acid softgel; and Caltranate, a blend of calcium formulated ...
3874 Fiscal Court
Riviera Beach, FL 33404-1785
Founded in 2004
Sancilio & Company, Inc. Announces Board Appointments
Jul 23 12
Sancilio & Company, Inc. announced the recent addition of Dr. Alan Dunton, Mr. Patrick Gray, Mr. Rod Jackson, Dr. Dennis Langer and Mr. Kelly Perkins to its Board of Directors. The new directors join the company's Chairman, Dr. Frederick Sancilio, who is also Founder, President and CEO. Most recently, Dunton served as President and Chief Executive Officer of Panacos Pharmaceuticals, Inc.
Sancilio & Company, Inc. Appoints New Board of Directors
Jul 23 12
Sancilio & Company, Inc. announced the recent addition of Dr. Alan Dunton, Mr. Patrick Gray, Mr. Rod Jackson, Dr. Dennis Langer and Mr. Kelly Perkins to its Board of Directors. The new directors join the company's Chairman, Dr. Frederick Sancilio, who is also Founder, President and CEO. Dr. Dunton is the founder and principal of Danerius, LLC. Dr. Dunton serves on several boards of directors, including EpiCept Corporation, as Non-Executive Chairman, Targacept, Inc., Oragenics, Inc. and Palatin Technologies Inc. Mr. Gray has 37 years of experience with PricewaterhouseCoopers in Boston, Philadelphia, New York, Vancouver and Florham Park, NJ, including 25 years as an Audit Partner. In 2005, Mr. Jackson established Cobalt Laboratories, Inc. Under Mr. Jackson's leadership, Cobalt developed a product line and grew annual revenues to $200 million. From 2005 to 2010, Dr. Langer served as a Managing Partner of Phoenix IP Ventures. Dr. Langer serves on several boards of directors, including Myriad Genetics, Inc., Myrexis, Inc., and Dicerna Pharmaceuticals, Inc., and is an Advisor to Investor Growth Capital. Dr. Langer is a Clinical Professor in the Department of Psychiatry, Georgetown University School of Medicine. Mr. Perkins is an original Principal, Executive Committee Member and Co-Chief Investment Officer of Lighthouse Partners.